Skip to main content
BrainCited

Omega-3 Fatty Acids (DHA/EPA) के लिए Depression-Related Cognitive Dysfunction

B

Research suggests fish oil supplements may help support memory function and are also associated with improved outcomes in people experiencing depression-related cognitive symptoms.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Ddepression\u002Dcognitive'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

निष्कर्ष

Research suggests fish oil supplements may help support memory function and are also associated with improved outcomes in people experiencing depression-related cognitive symptoms.

Key Study Findings

Review
The Clinical Implications of Ashwagandha (Withania somnifera L.) with a Special Reference to Side Effects-A …
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: narrative review of ashwagandha clinical trials and basic research (1994-present)

preclinical animal/in vitro study
Ashwagandha (Withania somnifera (L.) dunal) root extract containing withanolide a alleviates depression-like behavior in mice …
Dose: 60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL बनाम: Placebo प्रभाव: None None
Review
[Pharmacotherapies for insomnia].
Dose: Z-drugs, melatonin, orexin antagonists बनाम: None Outcome: Insomnia treatment efficacy and safety प्रभाव: None None

जनसंख्या: Adults with chronic insomnia

In Vitro
Oxytocin and Vasopressin Gene Expression in the Brain as Potential Biomarkers for Cannabidiol Therapeutic Efficacy.
Dose: Cannabidiol (CBD) बनाम: Vehicle control Outcome: Oxytocin and vasopressin gene expression प्रभाव: None None

जनसंख्या: EAE mouse model (multiple sclerosis)

Meta-Analysis
Effects of vitamins and polyunsaturated fatty acids on cognitive function in older adults with mild …
Dose: None बनाम: Control Outcome: Cognitive function प्रभाव: SMD = 0.58, 95% CI = [0.20, 0.96] P = 0.003

जनसंख्या: Patients with mild cognitive impairment

Controlled Clinical Trial
Prolonging effects of Valeriana fauriei root extract on pentobarbital-induced sleep in caffeine-induced insomnia model mice …
Dose: 5 g/kg or 10 g/kg (as VF) बनाम: Caffeine-induced insomnia without VF Outcome: Sleep latency and duration (pentobarbital-induced) प्रभाव: None None

जनसंख्या: Caffeine-induced insomnia model mice

Key Statistics

15

अध्ययन

2500

प्रतिभागी

Positive

B

ग्रेड

Referenced Papers

La Revue du … 2024
Nature reviews. Disease … 2021 163 उद्धरण
The Senior care … 2021 2 उद्धरण
Journal of ethnopharmacology 2020 85 उद्धरण
Current neurology and … 2019 11 उद्धरण
Sleep medicine 2017 95 उद्धरण
Current treatment options … 2017 56 उद्धरण
Clinical therapeutics 2016 328 उद्धरण
Molecular nutrition & … 2015 18 उद्धरण
Pharmacotherapy 2007 117 उद्धरण
The Cochrane database … 2003 263 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
1,000-2,000 mg combined DHA/EPA per day
cognitivesupport:
1,000-1,700 mg/day (optimal dose-response curve)

अधिकतम सीमा: 3,000 mg/day combined DHA/EPA (FDA GRAS)

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None -- Positive --
60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL -- Positive --
Z-drugs, melatonin, orexin antagonists -- Positive --
Cannabidiol (CBD) -- Positive --
None -- Positive --
5 g/kg or 10 g/kg (as VF) -- Positive --
10, 25, or 50 mg/kg body weight ashwagandha extract (AE, 35% withanolide glycosides, Shoden) -- Positive --
None -- Mixed --

सेवन का सर्वोत्तम समय: With meals containing fat for better absorption

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Fishy aftertaste or burping
  • Mild gastrointestinal discomfort
  • Potential increased bleeding time at very high doses
  • May lower blood pressure slightly

ज्ञात अंतःक्रियाएँ

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (may reduce omega-3 absorption)

सहनीय अधिकतम सेवन: 3,000 mg/day combined DHA/EPA (FDA GRAS)

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Omega-3 Fatty Acids (DHA/EPA) help with Depression-Related Cognitive Dysfunction?
Based on 15 studies with 2,500 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (DHA/EPA) may support Depression-Related Cognitive Dysfunction management. Our evidence grade is B (Good Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Depression-Related Cognitive Dysfunction?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Depression-Related Cognitive Dysfunction?
We rate the evidence as Grade B (Good Evidence). This rating is based on 15 peer-reviewed studies with 2,500 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Depression-Related Cognitive Dysfunction

Omega-3 Fatty Acids (DHA/EPA) अन्य स्वास्थ्य स्थितियों के लिए

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।